Inhibition of the proteasome reduces transfer-induced diabetes in nonobese diabetic mice

Scandinavian Journal of Immunology
J PetrovicP Höglund

Abstract

Inhibition of the 26S proteasome reduces the severity of several immune-mediated diseases. Here, we report that the proteasome also regulates transfer-induced diabetes in nonobese mice. Treatment of recipient mice with the proteasome inhibitor N(alpha)-benzyloxycarbonyl-l-leucyl-l-leucyl-l-leucinal (MG132) resulted in a 76% reduction in transfer-induced diabetes. The closely related inhibitor carbobenzoxy-l-leucyl-l-leucinal that inhibits calpains but not the proteasome had no protective effect, suggesting that MG132 acted via inhibition of the proteasome. MG132 decreased proliferation of transferred T cells in the pancreatic lymph nodes in vivo and prevented their expansion in a dose-dependent manner in vitro, consistent with a direct effect by MG132 on the T cells. MG132 did not prevent migration of transferred T cells into the islets but reduced the number of mice with severe infiltration. We suggest that MG132 prevents transfer-induced diabetes by directly targeting the autoreactive T cells and lowering their diabetogenic potential.

References

Mar 19, 1996·Proceedings of the National Academy of Sciences of the United States of America·I AndréD Mathis
Dec 12, 1997·European Journal of Immunology·X WangJ Wu
Jan 16, 1998·Immunity·A GonzalezD Mathis
Feb 26, 1998·Cell·W BaumeisterE Seemüller
Oct 28, 1998·Proceedings of the National Academy of Sciences of the United States of America·P AndréV Lotteau
Oct 28, 1998·Trends in Cell Biology·D H Lee, A L Goldberg
Dec 19, 1998·The EMBO Journal·A Ciechanover
Feb 5, 1999·European Journal of Immunology·I André-SchmutzD Mathis
Jun 8, 1999·Annual Review of Immunology·K L Rock, A L Goldberg
Jun 17, 1999·Nature Medicine·M A Atkinson, E H Leiter
Aug 19, 1999·The Journal of Allergy and Clinical Immunology·P J ElliottJ Adams
Sep 1, 1999·Proceedings of the National Academy of Sciences of the United States of America·L MengC M Crews
Oct 18, 2000·Proceedings of the National Academy of Sciences of the United States of America·F LuhderD Mathis
Aug 22, 2001·Chemistry & Biology·A F Kisselev, A L Goldberg
Dec 12, 2001·Seminars in Oncology·J Adams
Feb 14, 2002·Trends in Molecular Medicine·Luciano AdoriniLeonard C Harrison
Apr 3, 2002·Nature Medicine·Alfred L Goldberg, Kenneth Rock
Aug 7, 2002·The Journal of Experimental Medicine·Marie-Claude GagneraultFrançoise Lepault
Oct 24, 2002·Neurobiology of Aging·Gianluigi ForloniAlessandro Bertoli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.